Search

Author/Creator Musch, Mark W.

1. Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota. (13th October 2016)

Authors:
Wan, Jin‐Yi; Wang, Chong‐Zhi; Zhang, Qi‐Hui; Liu, Zhi; Musch, Mark W.; Bissonnette, Marc; Chang, Eugene B.; Li, Ping; Qi, Lian‐Wen; Yuan, Chun‐Su
Journal:
Biomedical chromatography
Issue:
Volume 31:Number 4(2017:Apr.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100). (22nd February 2018)

Authors:
Miyoshi, Jun; Nobutani, Kentaro; Musch, Mark W.; Ringus, Daina L.; Hubert, Nathaniel A.; Yamamoto, Masahiro; Kase, Yoshio; Nishiyama, Mitsue; Chang, Eugene B.
Other Names:
De Feo Vincenzo Academic Editor.
Journal:
Evidence-based complementary and alternative medicine
Issue:
Volume 2018(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Daikenchuto (TU‐100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal. Issue 5 (3rd October 2017)

Authors:
Nobutani, Kentaro; Miyoshi, Jun; Musch, Mark W.; Nishiyama, Mitsue; Watanabe, Junko; Kaneko, Atsushi; Yamamoto, Masahiro; Yoshida, Masaru; Kono, Toru; Jeong, Hyunyoung; Chang, Eugene B.
Journal:
Pharmacology research & perspectives
Issue:
Volume 5:Issue 5(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases. Issue 5 (May 2015)

Authors:
Huang, Edmond Y.; Inoue, Takuya; Leone, Vanessa A.; Dalal, Sushila; Touw, Ketrija; Wang, Yunwei; Musch, Mark W.; Theriault, Betty; Higuchi, Kazuhide; Donovan, Sharon; Gilbert, Jack; Chang, Eugene B.
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 5(2015:May)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Daikenchuto (TU‐100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer. (12th October 2016)

Authors:
Hasebe, Takumu; Matsukawa, Jun; Ringus, Daina; Miyoshi, Jun; Hart, John; Kaneko, Atsushi; Yamamoto, Masahiro; Kono, Toru; Fujiya, Mikihiro; Kohgo, Yutaka; Wang, Chong‐Zi; Yuan, Chun‐Su; Bissonnette, Marc; Musch, Mark W.; Chang, Eugene B.
Journal:
Phytotherapy research
Issue:
Volume 31:Number 1(2017)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K. Issue 1 (10th February 2016)

Authors:
Hasebe, Takumu; Ueno, Nobuhiro; Musch, Mark W.; Nadimpalli, Anuradha; Kaneko, Atsushi; Kaifuchi, Noriko; Watanabe, Junko; Yamamoto, Masahiro; Kono, Toru; Inaba, Yuhei; Fujiya, Mikihiro; Kohgo, Yutaka; Chang, Eugene B.
Journal:
Pharmacology research & perspectives
Issue:
Volume 4:Issue 1(2016:Feb.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗